Cigarette Smoking Reduction in Pregnant Women with Opioid Use Disorder

Anita Ram, Michelle Tuten, Margaret S Chisolm

Research output: Contribution to journalArticle

Abstract

Objectives: Nearly 95% of women with opioid use disorder continue to smoke cigarettes during pregnancy. Despite this prevalence and the well documented adverse effects of smoking on birth outcomes, cigarette smoking is underaddressed in this population. This study examines factors associated with successful smoking reduction among pregnant women with opioid use disorder and the impact of smoking reduction on maternal and birth outcomes. Methods: This study is a secondary data analysis of maternal smoking reduction and infant birth outcomes among pregnant women with opioid use disorder (N=118), enrolled in a randomized controlled trial of a contingency management intervention in which escalating monetary vouchers were provided to women who met escalating smoking-reduction targets. Results: Participants' ability to meet higher smoking reduction targets was associated with less cocaine use at baseline (P=0.022), higher carbon monoxide levels at baseline (P=0.039), fewer prior quit attempts (P=0.016), participation in the contingency management intervention, and greater adherence with the parent trial protocol. Some clinically relevant associations were found between smoking reduction and birth outcomes, including birth weight, spontaneous abortions, and neonatal abstinence syndrome treatment, but these differences did not reach statistical significance. Conclusions: Contingency management promotes smoking reduction, but other factors may be associated with such reduction, including baseline smoking and illicit drug use, prior quit attempts, and willingness to participate in the incentives program. Clinicians caring for pregnant women with opioid use disorder may see greater smoking behavior change if they first encourage smoking reduction before recommending smoking cessation. Future research is needed to determine the level of smoking reduction needed to positively impact birth outcomes.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
JournalJournal of Addiction Medicine
Volume10
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Opioid Analgesics
Pregnant Women
Smoking
Parturition
Neonatal Abstinence Syndrome
Mothers
Aptitude
Street Drugs
Spontaneous Abortion
Smoking Cessation
Carbon Monoxide
Clinical Protocols
Cocaine
Birth Weight
Smoke
Tobacco Products
Motivation
Randomized Controlled Trials
Pregnancy

Keywords

  • cigarette smoking
  • contingency management
  • nicotine
  • opioids
  • pregnancy
  • tobacco

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Cigarette Smoking Reduction in Pregnant Women with Opioid Use Disorder. / Ram, Anita; Tuten, Michelle; Chisolm, Margaret S.

In: Journal of Addiction Medicine, Vol. 10, No. 1, 01.02.2016, p. 53-59.

Research output: Contribution to journalArticle

@article{a392bfe7470f4f868d8735777d8cc02d,
title = "Cigarette Smoking Reduction in Pregnant Women with Opioid Use Disorder",
abstract = "Objectives: Nearly 95{\%} of women with opioid use disorder continue to smoke cigarettes during pregnancy. Despite this prevalence and the well documented adverse effects of smoking on birth outcomes, cigarette smoking is underaddressed in this population. This study examines factors associated with successful smoking reduction among pregnant women with opioid use disorder and the impact of smoking reduction on maternal and birth outcomes. Methods: This study is a secondary data analysis of maternal smoking reduction and infant birth outcomes among pregnant women with opioid use disorder (N=118), enrolled in a randomized controlled trial of a contingency management intervention in which escalating monetary vouchers were provided to women who met escalating smoking-reduction targets. Results: Participants' ability to meet higher smoking reduction targets was associated with less cocaine use at baseline (P=0.022), higher carbon monoxide levels at baseline (P=0.039), fewer prior quit attempts (P=0.016), participation in the contingency management intervention, and greater adherence with the parent trial protocol. Some clinically relevant associations were found between smoking reduction and birth outcomes, including birth weight, spontaneous abortions, and neonatal abstinence syndrome treatment, but these differences did not reach statistical significance. Conclusions: Contingency management promotes smoking reduction, but other factors may be associated with such reduction, including baseline smoking and illicit drug use, prior quit attempts, and willingness to participate in the incentives program. Clinicians caring for pregnant women with opioid use disorder may see greater smoking behavior change if they first encourage smoking reduction before recommending smoking cessation. Future research is needed to determine the level of smoking reduction needed to positively impact birth outcomes.",
keywords = "cigarette smoking, contingency management, nicotine, opioids, pregnancy, tobacco",
author = "Anita Ram and Michelle Tuten and Chisolm, {Margaret S}",
year = "2016",
month = "2",
day = "1",
doi = "10.1097/ADM.0000000000000186",
language = "English (US)",
volume = "10",
pages = "53--59",
journal = "Journal of Addiction Medicine",
issn = "1932-0620",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cigarette Smoking Reduction in Pregnant Women with Opioid Use Disorder

AU - Ram, Anita

AU - Tuten, Michelle

AU - Chisolm, Margaret S

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Objectives: Nearly 95% of women with opioid use disorder continue to smoke cigarettes during pregnancy. Despite this prevalence and the well documented adverse effects of smoking on birth outcomes, cigarette smoking is underaddressed in this population. This study examines factors associated with successful smoking reduction among pregnant women with opioid use disorder and the impact of smoking reduction on maternal and birth outcomes. Methods: This study is a secondary data analysis of maternal smoking reduction and infant birth outcomes among pregnant women with opioid use disorder (N=118), enrolled in a randomized controlled trial of a contingency management intervention in which escalating monetary vouchers were provided to women who met escalating smoking-reduction targets. Results: Participants' ability to meet higher smoking reduction targets was associated with less cocaine use at baseline (P=0.022), higher carbon monoxide levels at baseline (P=0.039), fewer prior quit attempts (P=0.016), participation in the contingency management intervention, and greater adherence with the parent trial protocol. Some clinically relevant associations were found between smoking reduction and birth outcomes, including birth weight, spontaneous abortions, and neonatal abstinence syndrome treatment, but these differences did not reach statistical significance. Conclusions: Contingency management promotes smoking reduction, but other factors may be associated with such reduction, including baseline smoking and illicit drug use, prior quit attempts, and willingness to participate in the incentives program. Clinicians caring for pregnant women with opioid use disorder may see greater smoking behavior change if they first encourage smoking reduction before recommending smoking cessation. Future research is needed to determine the level of smoking reduction needed to positively impact birth outcomes.

AB - Objectives: Nearly 95% of women with opioid use disorder continue to smoke cigarettes during pregnancy. Despite this prevalence and the well documented adverse effects of smoking on birth outcomes, cigarette smoking is underaddressed in this population. This study examines factors associated with successful smoking reduction among pregnant women with opioid use disorder and the impact of smoking reduction on maternal and birth outcomes. Methods: This study is a secondary data analysis of maternal smoking reduction and infant birth outcomes among pregnant women with opioid use disorder (N=118), enrolled in a randomized controlled trial of a contingency management intervention in which escalating monetary vouchers were provided to women who met escalating smoking-reduction targets. Results: Participants' ability to meet higher smoking reduction targets was associated with less cocaine use at baseline (P=0.022), higher carbon monoxide levels at baseline (P=0.039), fewer prior quit attempts (P=0.016), participation in the contingency management intervention, and greater adherence with the parent trial protocol. Some clinically relevant associations were found between smoking reduction and birth outcomes, including birth weight, spontaneous abortions, and neonatal abstinence syndrome treatment, but these differences did not reach statistical significance. Conclusions: Contingency management promotes smoking reduction, but other factors may be associated with such reduction, including baseline smoking and illicit drug use, prior quit attempts, and willingness to participate in the incentives program. Clinicians caring for pregnant women with opioid use disorder may see greater smoking behavior change if they first encourage smoking reduction before recommending smoking cessation. Future research is needed to determine the level of smoking reduction needed to positively impact birth outcomes.

KW - cigarette smoking

KW - contingency management

KW - nicotine

KW - opioids

KW - pregnancy

KW - tobacco

UR - http://www.scopus.com/inward/record.url?scp=84959157156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959157156&partnerID=8YFLogxK

U2 - 10.1097/ADM.0000000000000186

DO - 10.1097/ADM.0000000000000186

M3 - Article

C2 - 26690292

AN - SCOPUS:84959157156

VL - 10

SP - 53

EP - 59

JO - Journal of Addiction Medicine

JF - Journal of Addiction Medicine

SN - 1932-0620

IS - 1

ER -